Industry News
-
New Approach Streamlines Stem Cell Collection for Sickle Cell Gene Therapy in First-in-Human Trial
Aug 25 2026 -
Cellenkos Receives FDA Fast Track Designation for Cord Blood-Derived Treg Cell Therapy in ALS
Aug 25 2026 -
Mahzi Therapeutics Receives FDA Rare Pediatric Disease Designation for AAV9 Gene Therapy in Pitt Hopkins Syndrome
Aug 25 2026 -
Rznomics Joins Lilly Gateway Labs to Advance RNA-Based Gene Therapies
Aug 24 2026 -
Ultragenyx Wins First FDA Approval for a One-Time AAV Gene Therapy in Glycogen Storage Disease Type Ia
Aug 20 2026 -
Manufacturing and Vector Advances Set to Expand Patient Access to CAR T Therapies
Aug 19 2026 -
Researchers Flag Viral Vector Manufacturing as a Key Bottleneck for Gene Therapy, Citing AAV Purification Limits
Aug 19 2026 -
Moderna and Merck Report Positive Phase 3 Results for Individualized mRNA Cancer Vaccine in Melanoma
Aug 19 2026 -
FDA Approves First mRNA Flu Vaccine in the U.S., Though Commercial Path Remains Uncertain
Aug 17 2026